China, Sept. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Using Artificial Intelligence to Analyze Ultrasound and Mammography Images for Distinguishing Benign from Malignant BI-RADS Category 4 Breast Lesions'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600132971
Registration Time: 2026/09/20
Type: Observational study
Primary Sponsor: Affiliated Qingyuan Hospital, Guangzhou Medical University (Qingyuan People's Hospital)
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=341446
Published by HT Digital Content Services with permission from Health Daily Digest....